University at Buffalo: Study - In Prostate Cancer, Intermittent Fasting is Found to Enhance Efficacy of Anti-androgen Therapy
August 12, 2025
August 12, 2025
BUFFALO, New York, Aug. 12 -- The University at Buffalo (State University of New York) issued the following news release:
* * *
Study: In prostate cancer, intermittent fasting is found to enhance efficacy of anti-androgen therapy
BUFFALO, N.Y. - Researchers have shown for the first time that intermittent fasting increases the efficacy of anti-androgen therapy in prostate cancer, according to a paper reporting preclinical results published in Cancer Research . . .
* * *
Study: In prostate cancer, intermittent fasting is found to enhance efficacy of anti-androgen therapy
BUFFALO, N.Y. - Researchers have shown for the first time that intermittent fasting increases the efficacy of anti-androgen therapy in prostate cancer, according to a paper reporting preclinical results published in Cancer Research . . .